Hormonal Influence on Mood Dysregulation: A Case of Bipolar Disorder with Endometriosis
Authors:
Open Access
- 4 September 2025
- journal article
- Published by Yayasan Sinergi Kawula Muda in Sinergi International Journal of Psychology
- Vol. 3 (4) , 189-199
Abstract
Bipolar disorder often coexists with gynecological conditions such as endometriosis, presenting clinical challenges due to overlapping hormonal and neuropsychiatric influences. The impact of hormonal therapy on mood stability in women with affective disorders remains underexplored. We report the case of a 30-year-old woman with bipolar II disorder, stable for nearly two years on lamotrigine, who developed mood destabilization after initiating hormonal treatment for stage III endometriosis. Sequential regimens—dienogest, norethisterone, and ethinylestradiol–levonorgestrel—were temporally associated with new or worsening mixed affective symptoms, including agitation, insomnia, irritability, and emotional lability, despite adherence to mood stabilizers. Her Hamilton Depression Rating Scale score increased from 9 to 21 within three months, with laboratory evaluation showing elevated estradiol and suppressed luteinizing hormone, supporting a hormone-related mechanism. A structured literature review (PubMed, Scopus, Google Scholar, 2000–2024) identified limited but consistent evidence that synthetic progestins may exacerbate psychiatric symptoms in mood-vulnerable populations through neuroendocrine and neurotransmitter modulation. This case underscores the importance of recognizing hormonally induced mood dysregulation in women with pre-existing psychiatric disorders and highlights the need for proactive management strategies. We recommend pre-treatment psychiatric screening, structured and longitudinal mood monitoring throughout hormonal therapy, and close interdisciplinary collaboration between gynecology and psychiatry to optimize outcomes. Integrated care approaches may reduce the risk of mood destabilization, enhance safety, and improve quality of life for women facing the dual burden of bipolar disorder and endometriosis.Keywords
This publication has 21 references indexed in Scilit:
- Gut Microbiome–Brain Alliance: A Landscape View into Mental and Gastrointestinal Health and DisordersACS Chemical Neuroscience, 2023
- Self-critical thinking mediates the relationship between perfectionism and perceived stress in undergraduate students: A longitudinal studyJournal of Affective Disorders Reports, 2022
- Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019The Lancet Psychiatry, 2022
- Safety and Effectiveness of Dienogest (Visanne®) for Treatment of Endometriosis: A Large Prospective Cohort StudyReproductive Sciences, 2020
- Mental health in women with endometriosis: searching for predictors of psychological distressHuman Reproduction, 2017
- Why is depression more common among women than among men?The Lancet Psychiatry, 2017
- Reproductive Steroid Regulation of Mood and BehaviorComprehensive Physiology, 2016
- Bipolar disorderThe Lancet, 2016
- The role of inflammation in depression: from evolutionary imperative to modern treatment targetNature Reviews Immunology, 2015
- The role of reproductive hormones in postpartum depressionCNS Spectrums, 2014